__timestamp | ADMA Biologics, Inc. | Geron Corporation |
---|---|---|
Wednesday, January 1, 2014 | 4823869 | 16758000 |
Thursday, January 1, 2015 | 6745968 | 17793000 |
Friday, January 1, 2016 | 8494742 | 18761000 |
Sunday, January 1, 2017 | 18092835 | 19287000 |
Monday, January 1, 2018 | 22502922 | 18707000 |
Tuesday, January 1, 2019 | 25910757 | 20893000 |
Wednesday, January 1, 2020 | 35050817 | 25678000 |
Friday, January 1, 2021 | 42896889 | 29665000 |
Saturday, January 1, 2022 | 52458024 | 43628000 |
Sunday, January 1, 2023 | 59020000 | 69135000 |
Unlocking the unknown
In the competitive world of biotechnology, managing expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of ADMA Biologics, Inc. and Geron Corporation from 2014 to 2023. Over this period, ADMA Biologics saw a staggering 1,125% increase in SG&A expenses, starting from a modest $4.8 million in 2014 to nearly $59 million in 2023. Meanwhile, Geron Corporation's expenses grew by approximately 312%, from $16.8 million to $69 million.
These trends highlight the differing strategic approaches of these companies in navigating the biotech landscape.
AstraZeneca PLC vs ADMA Biologics, Inc.: SG&A Expense Trends
Pfizer Inc. and Geron Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Geron Corporation
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Geron Corporation
Cost Management Insights: SG&A Expenses for Incyte Corporation and Geron Corporation
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Geron Corporation
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs ADMA Biologics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Opthea Limited vs Geron Corporation
Comparing Cost of Revenue Efficiency: ADMA Biologics, Inc. vs Geron Corporation
Who Optimizes SG&A Costs Better? ADMA Biologics, Inc. or Evotec SE
Who Optimizes SG&A Costs Better? CRISPR Therapeutics AG or Geron Corporation
SG&A Efficiency Analysis: Comparing Ligand Pharmaceuticals Incorporated and Geron Corporation